Eléments de l'association

	Eduardo Tolosa	11
	Neuroprotective Agents (therapeutic use)	5
	Eduardo Tolosa *Sauf* Neuroprotective Agents (therapeutic use)"	9
	Neuroprotective Agents (therapeutic use) *Sauf* Eduardo Tolosa"	3
	Eduardo Tolosa Et Neuroprotective Agents (therapeutic use)	2
	Eduardo Tolosa Ou Neuroprotective Agents (therapeutic use)	14
	*Corpus*	679

List of bibliographic references

Number of relevant bibliographic references: 2.

Ident.	Authors (with country if any)	Title
000231	Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne]	Validation of the freezing of gait questionnaire in patients with Parkinson's disease
000308	C. Warren Olanow [États-Unis] ; Robert A. Hauser [États-Unis] ; Joseph Jankovic [États-Unis] ; William Langston [États-Unis] ; Anthony Lang [Canada] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Fabrizio Stocchi [Italie] ; Eldad Melamed [Israël] ; Eli Eyal [Israël] ; Olivier Rascol [France]	A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024